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ABSTRACT
With the advent of automated and high-throughput
techniques, the number of patent applications con-
taining biological sequences has been increasing
rapidly. However, they have attracted relatively little
attention compared to other sequence resources. We
have built a database server called Patome, which
contains biological sequence data disclosed in
patents and published applications, as well as their
analysis information. The analysis is divided into two
steps. The first is an annotation step in which the
disclosed sequences were annotated with RefSeq
database. The second is an association step where
the sequences were linked to Entrez Gene, OMIM and
GO databases, and their results were saved as a
gene–patent table. From the analysis, we found that
55% of human genes were associated with patenting.
The gene–patent table can be used to identify
whether a particular gene or disease is related to
patenting. Patome is available at http://www.patome.
org/; the information is updated bimonthly.
INTRODUCTION
Recent advances in high-throughput sequencing technologies
have enabled us to determine many genomic sequences
quickly and cheaply. The use of biological sequence informa-
tion has greatly facilitated the R&D process in the pharma-
ceutical, agricultural, medical and chemical industries (1).
Filing a patent application is the key step to protect sequence
intellectual property. Sequences patent owners can gain
tremendous value and control over the exploitation of the
sequences (2). Over the past several decades, the number of
patent applications containing nucleic acid or amino acid
sequences has been increasing rapidly.
For patent-related biological sequences, there are both
public and commercial databases that provide patent
information (3). Public efforts are represented by GenBank
(4), the European Molecular Biology Laboratory (EMBL)
(5) and the DNA Database of Japan (DDBJ) (6). GenBank
obtains patent sequences from the patents issued by the US
Patent and Trademark Ofﬁce (USPTO). EMBL and DDBJ
also obtain sequences from their respective patent ofﬁces.
The websites of these three public databases offer patent
sequence data downloading, simple keyword searching and
alignment searching. In addition, PatGen (7), an integrated
database containing sequence data from public resources,
provides access to non-redundant sequence information, as
well as an abstract service. The commercial sector is led
by Chemical Abstract Service (http://www.cas.org/) and
Derwent (http://www.derwent.com/) with their corresponding
databases: CAS Registry and Derwent GENESEQ.
Although these patent databases provide good information
on patent-related sequences, they have little biological
information on the sequences, except for their organism
information. The mapping of the sequences and biological
resources, such as gene and disease, will provide an opportu-
nity for understanding of bio-resources’ patentable targets (8).
Especially, patent-related gene information can be used to
identify whether a particular gene has been patented or pub-
lished and to reveal if a patent has been infringed upon (9).
Recently, Jensen and Murray (10) reported that  20% of
human genes have been claimed as US intellectual property
from the analysis of the sequences in US patents with bioinfor-
matical methods. However, they used only the sequences at
GenBank, and their analysis was focused on human genes.
According to their knowledge, no attempt has been made to
annotate the biological sequences in patents or applications
thoroughly and to analyze them from a biological perspective.
In this report, we describe Patome, a database server con-
taining the patent-related biological sequences and their anal-
ysis data. To build Patome, we downloaded sequence data
from publicly available databases and created a non-
redundant sequence set. The non-redundant sequences were
annotated with RefSeq (11) and associated with Entrez
Gene (12), the Online Mendelian Inheritance in Man
(OMIM) (13) and Gene Ontology (GO) (14). The annotation
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database and served via web-based user interfaces.
DATABASE CONTENTS AND
ANALYSIS PIPELINE
Dataset
We downloaded the sequences from the patent divisions of
GenBank (ftp://ftp.ncbi.nih.gov/genbank), EMBL (ftp://ftp.
ebi.ac.uk/pub/databases/embl/patent), and DDBJ (ftp://ftp.
ddbj.nig.ac.jp/database/ddbj). Sequence data were also
obtained from the World Intellectual Property Organization
(WIPO) (ftp://ftp.wipo.int/pub/published_pct_sequences)
and the Publication Site for Issued and Published Sequences
(PSIPS) database (http://seqdata.uspto.gov/) maintained by
USPTO. As PSIPS does not provide a conventional ftp ser-
vice, we downloaded sequence listings one-by-one from the
PSIPS search interface. All the sequences obtained were
derived from the sequence listings disclosed in the issued
patents or published patent applications mainly in USA,
Japan, Europe and by WIPO.
We created a non-redundant sequence set by removing the
redundancy in the ﬁve databases. If the sequences had the
same publication number and the same SEQID, they were
considered duplicates. As on June 1,2006, the number of
non-redundant sequences were 38151115, including
34762740 nucleic acid sequences and 3388375 amino acid
sequences.
In the non-redundant sequences, there is a large number of
short fragments, which are mostly primers or synthetic con-
structs. These fragments are very short and not directly
related to gene functions. Therefore, we excluded the nucleic
acids (<100 bases) and the amino acids (<10 residues) in a
similarity-based annotation. The sequence data also had
many spelling errors and informal names in their organism
ﬁelds. They were corrected either by using NCBI taxonomy
database or manually for use in the next process.
Annotating the disclosed sequences
We developed an automated pipeline to identify the genes
from which the disclosed sequences were derived
(Figure 1). First, the nucleic acid sequences were compared
with both the RefSeq mRNA database and complete
sequenced microbial mRNA by using BALSTN (15). The
amino acid sequences were compared with RefSeq proteins
by using BALSTP. In the patent ﬁeld, BLAST search is a
general method that is used to identify functions of unknown
sequences and to determine whether sequences are novel
(16). The BLAST results were ﬁltered by 98% identity and
an E-value of 1 · 10
 20.
In general, the BLAST program was widely used to identi-
fy cDNAs or proteins similar to a query sequence by retriev-
ing putative homologs with performing local alignments (17).
Thus, their results could have orthologous sequences of query
sequences (e.g. human query sequence matches with mouse
sequences of RefSeq). In the study, the main purpose of
BLAST searching is to ﬁnd gene sequences of the query
sequences. Therefore, we applied two additional ﬁltering
methods to the BLAST results, in order to remove orthologs
and ﬁnd the exact gene in the same organism as that of a
query sequence.
First, we utilized the organism name of a query sequence,
called an organism comparison method, in which an organism
of the best hit RefSeq should be the same as that of the query
sequence. By applying this method, spurious matches to
orthologous genes could be ﬁltered out. However, this
method could not be applied if a query’s organism was
unknown.
Second, we applied a coverage method. If a sequence was
derived from a gene sequence, it should either contain most
of the gene sequence or be a part of it. Hence, we divided
the BLAST results into two types according to the alignment
coverage against RefSeq sequences. They are full- and
partial-length type. The full-length type is deﬁned if an align-
ment length is >80% of that of the matched RefSeq sequence.
The partial-length type is deﬁned if an alignment length is
>95% of that of the query sequence, except full-length
types. BLAST alignments should be either full-length or
partial-length type to go through the ﬁltering.
From the ﬁltered BLAST results, the sequence function was
assigned with the best RefSeq hit. Of the 8471504 nucleic
acid sequences, 1075764 (13%) were annotated with RefSeq
mRNAs or microbial mRNAs. Of the 2470671 amino acid
sequences, 1486625 (50%) were annotated with RefSeq
Figure 1. Overview of the analysis flow in Patome. The downloaded
sequences are divided into nucleic acids and amino acids. Nucleic acids are
annotated with both RefSeq mRNAs and microbial mRNAs. Amino acids are
annotated with RefSeq proteins. The BLAST results are filtered with three
filtering methods: E-value & percent identity, organism comparison and
coverage. From the mapping between the annotated data and biological
database information (Gene, GO, OMIM), a gene–patent association table is
built. The Patome database is constructed to store annotation and analysis
data and to make this information available to users via web interfaces.
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tion table that consists of the patent information (publication
and SEQID) and the annotation information (RefSeq number,
alignment length, alignment coverage and type, and E-value).
Building a gene–patent association table
RefSeq numbers of the annotation table served as a bridge to
link the disclosed sequences and gene information, whose
association can be represented as a gene–patent table that
contains genes and their related patent sequence information.
To build the gene–patent table, we extracted linking informa-
tion between the sequences and the corresponding RefSeq
number from the annotation table, and their relationship
was translated to a gene–patent table by using a gene2refseq
ﬁle from the Entrez Gene database. Entrez Gene also has
cross-link information to other biological databases repre-
sented by gene2GO and mim2gene ﬁles. These cross-links
were added into the gene–patent table.
For example, if two sequences from a ‘SEQID 39020 of
WO0171042’ and a ‘SEQID 20352 of US6703491’ are
assigned a RefSeq number, ‘NM_143536’, in the annotation
Figure 2. Output of the Patome search. (A) Output of only patent (or application) number search. (B) Output of both patent (or application) number and SEQID
search.
Table 1. Summary of patent-related genes in the major organisms
Organism No. of
genes
a
No. of
patent-related
genes
Patent-related
genes (in %)
Homo sapiens 39216 21478 55
Oryza sativa 47275 12045 25
Drosophila melanogaster 21146 8503 40
Arabidopsis thaliana 31386 5262 17
Mus musculus 60714 4479 7
Rattus norvegicus 23973 3542 15
aThe number of genes is from NCBI Entrez Gene.
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linked to the two sequences. As the RefSeq number,
‘NM_143536’ was cross-linked with a GeneID ‘43614’ in
the gene2refseq, we can conclude that the GeneID, ‘43614’
was disclosed twice in issued patents or patent applications.
From the analysis of the sequences, we found that 55%
of the human genes were associated with patents or patent
applications, the highest percentage among organisms.
Oryza sativa (rice) ranked second with 25% (12045
genes). The summary of patent-related genes in the major
organisms is shown in Table 1. For the gene–patent analysis,
it is necessary to distinguish sequences of granted patents
from those of patent applications (18). Only granted patents
are given intellectual property rights. In this study, the
sequences were derived from either issued patents or pub-
lished patent applications. Accordingly, it cannot be guaran-
teed that the genes appearing in the gene–patent table are
patented.
SEARCHING AND DOWNLOADING
THE PATOME DATABASE
Patome database server is composed of a web interface and
an MySQL database management system. The web interface
is implemented in static HTML pages, Java Server Pages
(JSP) (http://java.sun.com/products/jsp/) and servlet (http://
java.sun.com/products/servlet/) programs for database
searching. MySQL is used to store the disclosed sequence
information and their annotation and analysis data.
Patome can be accessed through web interface for querying
(Figure 2). The querying interface allows the user to search
against the patent sequence data and their analysis data.
The patent sequence data can be searched by patent (or
application) number, GenBank accession number and title.
The search results consist of sequence information (length,
type, organism, sequence), annotation information (Refseq,
gene, GO, OMIM, coverage) if it exists and the same
sequences information as a query. The analysis data search
interface allows the user to search for the gene name (or sym-
bol), Entrez Gene ID and RefSeq number. In addition, the
logical operators, OR (j) and AND (&), can be used to com-
bine search words in the title and gene searches.
The display of search results also contains outgoing links
to external databases for sequences and patents. For example,
patent (or application) numbers are linked to the USPTO
database (http://www.uspto.gov/patft/index.html) for US
patents or applications, and the esp@cenet patent database
server (http://ep.espacenet.com/) at the European Patent
Ofﬁce for the others. Gene names in the search output are
linked to Entrez Gene and Reactome (19). The entire content
of Patome annotation data is available for download from our
website. We provide a zip-compressed annotation ﬁle. The
data are presented in simple tab-delimited text ﬁle (for easy
parsing of the data).
Detailed statistics on patent sequences are provided in the
‘statistics’ link on the Patome homepage. This includes the
national (including WIPO), length and organism distributions
of the sequences. These distributions are represented as
tables. We also present statistics on gene-associated patents
of major organisms in the homepage.
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